Photodynamic Therapy for Lung Cancer

Photodynamic therapy (PDT) is a type of cancer treatment in which you receive a light-activated drug that tends to collect in cancer cells. Some time later, the cells are exposed to a special light, which converts the drug into a new form that kills the cancer cells.

For people with stage 0 lung cancers (small cancers that have not spread beyond the lining layer of cells in the lungs), PDT may be an option to cure the cancer. For people whose lung cancers are at a more advanced stage, PDT can be used to shrink tumors blocking an airway to help improve the quality of life.

PDT offers hope

Most lung cancers start in the lining of the bronchi, the tubes that branch into the lungs from the windpipe. But, unfortunately, only a small number of lung cancers are detected at an early stage, before they have grown larger or spread.

In carefully selected people whose tumors are small (less than 1 cm) and near the surface of the bronchi, PDT can provide five-year survival rates comparable to those for radiation treatment or surgery.

Beyond the possible cure that PDT offers for the few people whose lung cancer is found early, it can also be used to control some of the symptoms of more advanced lung cancer. That can improve the quality of life for a person with cancer. Here are some examples:

PDT can help improve the quality of life for someone whose advanced tumor is so large that it interferes with breathing. The procedure can be used to reduce symptoms by shrinking the obstructive tumor. In these situations, PDT is as efficient as some other palliative methods, including electrosurgery, Nd-YAG laser, and brachytherapy.

PDT can be used when a cancer reoccurs in an airway in a place that was previously treated with radiotherapy.

Possible future improvements for PDT

PDT has many advantages. It can be done as an outpatient, has few long-term side effects when used correctly, is less invasive than surgery, causes little scarring, can be targeted at only cancer cells, and can be repeated if needed. The main drawback of PDT is that the IV drugs remain in the person's skin for four to six weeks, which means that the person must stay totally out of the sun or risk getting a severe sunburn. It's use is also limited to areas that can be reached with light, and it cannot be used to treat large tumors. This may change if drugs of the future are stronger. Another research direction is to develop new agents that are retained in the cancer cells longer, but clear from the skin cells faster.

Putting PDT to work

Though this treatment has been evolving for decades, it has been slow to catch on. Even so, many centers in the United States offer PDT, as do several scattered through Europe, Japan, and Canada.

People with lung cancer can locate a center by asking for a referral from their doctor. They can also find centers by searching the Internet, with assistance from a medical librarian.

For now, PDT is a procedure that can help only a small number of people diagnosed with lung cancer.